Overview

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Dosing methods for digoxin, a drug used to treat heart failure, have not been updated in decades despite evidence in recent years suggesting that blood levels of digoxin achieved with traditional dosing practices may increase the risk of adverse events. We developed a simple dosing tool that targets lower blood levels of digoxin that have been associated with improved outcomes compared to higher blood levels. The aim of this study is to determine if this simplified dosing tool is more effective than standard digoxin dosing practices at achieving lower blood levels and also to determine if digoxin dosing may be further optimized by incorporating patients' genetic information believed to influence the drug's properties.
Phase:
Phase 4
Details
Lead Sponsor:
University of Illinois at Chicago
Collaborator:
American College of Clinical Pharmacy
Treatments:
Digoxin